29 C
Vientiane
Tuesday, April 29, 2025
spot_img
Home Blog Page 294

Vixtel and EE Group Australia Join Forces to Expand into the Australian AI Perception Intelligence Market

HONG KONG, March 28, 2025 /PRNewswire/ — EE Group Australia, a leading Australian provider of innovative technology products, and Vixtel Technologies (an indirectly wholly-owned subsidiary of International Business Digital Technology (HKEX stock code: 1782)), a leader in AI perception intelligence, today announced a strategic partnership. EE Group Australia will become a tier-one distributor for Vixtel’s AI perception intelligence products, leveraging its extensive customer network and strong channel advantages to help Vixtel introduce its leading perception intelligence technology and products to the Australian market and jointly explore new opportunities in the AI perception intelligence landscape.

Vixtel’s AI perception intelligence products maintain a leading position in the industry

Vixtel has been deeply involved in the AI perception intelligence field for many years, possessing independently developed deep learning algorithms and advanced hardware design capabilities. Its product portfolio includes unmanned aerial vehicle (UAV) intelligent management platforms, intelligent video surveillance systems, AI edge computing boxes, intelligent perception observable centers, intelligent computing power analysis and scheduling decision-making management platforms. These are widely used in various fields such as intelligent video, smart ports, smart mining, smart energy, and intelligent transportation. Known for high precision, efficiency, and reliability, Vixtel’s AI perception intelligence products maintain a leading position in the industry. Its intelligent video management system has processed data from hundreds of millions of terminals, demonstrating exceptional reliability and scalability.

EE Group Australia, a leading Australian supplier of innovative technology products serving both consumer and enterprise markets, is the exclusive distributor for DJI Enterprise, providing cutting-edge solutions to businesses. In addition, EE Group Australia offers DJI Agriculture products and other leading brands such as Insta360 and ECOFLOW smart power solutions, ensuring a comprehensive portfolio of advanced technology products. Through this partnership, EE Group Australia will fully utilize its extensive channel advantages and professional customer service capabilities, particularly its experience in enterprise-level solutions, to provide Vixtel with comprehensive support from product promotion and sales to after-sales service, helping Vixtel rapidly penetrate the Australian market and enhance its brand influence.

EE Group helps Vixtel introduce its leading perception intelligence technology and products to the Australian market

This collaboration represents a strategic choice for both parties, leveraging complementary strengths and creating mutual benefits. Vixtel can leverage EE Group Australia’s extensive customer network and mature distribution channels to rapidly increase its market share and accelerate its business development. EE Group Australia, in turn, can enrich its product portfolio by introducing Vixtel’s leading AI perception intelligence products, particularly strengthening its capabilities in enterprise-level AIoT solutions and providing customers with more comprehensive and advanced technical services.

Colin Sze, CEO of EE Group Australia, stated, “Vixtel has demonstrated cutting-edge technology and extensive application experience in providing business intelligence perception and management solutions for large network operators and enterprises. The digital upgrade of industries in Australia has vast market potential. By leveraging EE Group Australia’s extensive channel network and professional service capabilities, Vixtel’s AI perception intelligence products can be rapidly localized, fully realizing the enormous market potential of AI technology empowering industry applications.”

Haiqing Guan, CEO of Vixtel, stated, “Our AI perception intelligence products are at the forefront of the industry, with rich practical experience. For example, our intelligent video management system has processed data from hundreds of millions of terminals, demonstrating extremely high reliability. Australia has a large number of industry application scenarios, making it very suitable for introducing intelligent perception technology to enhance intelligent operation capabilities. With EE Group Australia’s local resources and mature distribution network, we can deeply explore market demand, cultivate long-term customer groups, and achieve mutual success.”

Inflation in Laos Drops to 11.2% in March

Inflation in Laos Drops to 11.2% in March
Vientiane Capital landscape (photo credit: Oulayvanh SIsounonth)

Laos’ inflation rate eased to 11.2 percent in March, down from 12.7 percent in February and 15.5 percent in January, according to the Lao Statistics Bureau. 

Phong Nha in Vietnam is the Cheapest Destination on Agoda this spring

HONG KONG, March 28, 2025 /PRNewswire/ — Digital travel platform Agoda has unveiled its list of the most affordable destinations for spring travel in April and May 2025. From serene beaches to bustling cities, these destinations offer budget-conscious travelers a chance to explore without breaking the bank. Phong Nha, Vietnam, tops the list with an average room rate of just $28 per night*, making it an ideal choice for those seeking adventure and natural beauty this spring. 

Phong Nha is joined in the top three by Tirupati, India, and Hat Yai, Thailand, with average room rates of $34 and $40 per night, respectively. These destinations provide a mix of cultural, culinary, and scenic experiences, perfect for spring getaways. 

Matteo Frigerio, Chief Marketing Officer at Agoda, shared, “April and May are peak travel months in Asia, with holidays like Golden Week in Japan and Songkran in Thailand driving demand. But travelers can rest assured—Agoda offers great value on accommodation, flights, and activities, with plenty of affordable destinations proving that budget-friendly travel is still within reach, even during the busiest seasons.” 

The Cheapest Spring Destinations ranking is based on average room rates in the twenty most popular destinations across nine Asian markets, offering travelers a snapshot of affordable options. 

  1. Phong Nha, Vietnam ($28
    Known for its breathtaking caves and lush landscapes, Phong Nha is a haven for nature lovers. Visitors can explore the UNESCO-listed Phong Nha-Ke Bang National Park, home to some of the world’s largest caves, or enjoy a tranquil boat ride along the Son River. The area also offers opportunities for hiking, cycling, and immersing in local culture. 
  2. Tirupati, India ($34
    Tirupati is home to the famous Venkateswara Temple, one of the most visited pilgrimage sites in the world, renowned for its Tirupati laddu, a unique sweet offering with deep cultural and religious significance. Beyond its spiritual appeal, the city offers a rich cultural experience with vibrant festivals, traditional music, and delicious South Indian cuisine. Visitors can also explore nearby attractions like the serene Talakona Waterfalls, the lush Sri Venkateswara National Park, and the historic Chandragiri Fort, adding both natural beauty and historical depth to their journey. 
  3. Hat Yai, Thailand ($40
    Hat Yai ranked top in Agoda’s Cheapest Christmas Destinations rank and holds on to a podium place in the traditionally popular spring months in which Thailand celebrates Songkran and other holidays. Hat Yai is known for its many markets and tasty street food, and the city also serves as a gateway to nearby beaches and islands, making it a versatile destination for spring. 
  4. Padang, Indonesia ($40
    Famous for its culinary heritage, Padang is a paradise for food enthusiasts, offering iconic dishes like Rendang and Sate Padang. Visitors can also explore its stunning beaches, such as Air Manis Beach, or take a short trip to the Mentawai Islands for surfing and snorkeling. The city’s rich history and cultural landmarks add to its charm. 
  5. Bacolod, Philippines ($46
    Known as the “City of Smiles,” Bacolod offers a warm welcome and a laid-back vibe. Travelers can explore historical landmarks like The Ruins, a grand mansion from the early 1900s, or enjoy the city’s mouthwatering food scene, including its famous chicken inasal. Bacolod’s friendly locals and colorful festivals make it a delightful spring destination. 
  6. Kuala Terengganu, Malaysia ($48
    A coastal gem, Kuala Terengganu boasts beautiful beaches, traditional crafts, and lively markets. Visitors can explore the city’s iconic Crystal Mosque or take a boat ride to the nearby Redang Island for snorkeling and diving. The city’s rich cultural heritage, including its batik-making traditions, offers a unique experience for travelers. 
  7. Gimpo, South Korea ($66
    Located near Seoul, Gimpo offers a quieter alternative with scenic parks and cultural sites. Visitors can enjoy a look around the National Aviation Museum or explore the Gimpo Sculpture Park. The city’s beautiful natural scenery including the Munsu Mountain and the Han River makes it an excellent destination for a peaceful appreciation of South Korea’s springtime beauty and cherry blossoms. 
  8. Narita, Japan ($71
    Beyond its Tokyo-servicing airport, Narita is a charming city with historic temples and picturesque gardens. Visitors can explore Naritasan Shinshoji Temple, a centuries-old Buddhist temple surrounded by tranquil grounds. Spring travelers can also enjoy cherry blossoms at Naritasan Park and sample local delicacies like unagi (grilled eel). 
  9. Pingtung, Taiwan ($79
    Pingtung is a gateway to Taiwan’s southern beauty, offering beaches, night markets, and a rich cultural heritage. Visitors can explore Kenting National Park, known for its dramatic coastal scenery and outdoor activities. The city’s markets and local cuisine provide a taste of Taiwan’s unique flavors.

With over 5 million holiday properties, 130,000 flight routes, and 300,000 activities available, Agoda makes it easy to plan your perfect spring getaway. Visit Agoda.com/deals or download the Agoda mobile app for the best deals. 

 

Perfect Sync to Win: Unlock the Full Power of PCIe 5.0 Graphics with GIGABYTE B760 GEN5 Motherboards

TAIPEI, March 28, 2025 /PRNewswire/ — GIGABYTE, the world’s leading computer brand, proudly announces the launch of its latest B760 GEN5 series motherboards, bringing PCIe 5.0 support to the best-selling AORUS ELITE, GIGABYTE GAMING, and UD series. These new motherboards are designed to unlock gaming performance, offering smoother gameplay, higher frame rates, and reduced latency. By fully supporting the latest NVIDIA RTX 50 series and AMD Radeon RX 9000 series graphics cards, the GIGABYTE B760 GEN5 series is the best entry gateway for gamers to experience the latest PCIe 5.0 technology.

Perfect Sync to Win: Unlock the Full Power of PCIe 5.0  Graphics with GIGABYTE B760 GEN5 Motherboards
Perfect Sync to Win: Unlock the Full Power of PCIe 5.0 Graphics with GIGABYTE B760 GEN5 Motherboards

Thermal design is one of the key factors when it comes to performance. To ensure optimal thermal efficiency, the AORUS ELITE models are equipped with fully covered heatsinks and M.2 Thermal Guards to maximize system stability under heavy workloads. The GIGABYTE GAMING and UD series are designed with enlarged VRM thermal armor that ensures consistent high-speed performance for gaming and creative tasks.

Moreover, the GIGABYTE B760 GEN5 series motherboards feature DIY-friendly designs, making component swapping much easier. The WIFI EZ-Plug design integrates Wi-Fi antenna plugs into one adapter, relieving users from the troublesome screwing required during installation. Accomplished with PCIe EZ-Latch, making graphics card installation and removal quick and effortless. The M.2 EZ-Latch allows screwless installation and release on the M.2 SSD. Leveraging GIGABYTE’s Ultra Durable™ technology, these boards are built with high-quality components and PCIe UD Slot Armor, reinforcing structural integrity for heavy graphics cards.

GIGABYTE PCIe 5.0-supported B760 GEN5 series motherboards will be available in mid-April. For more details, please visit the official product page.

Wai Yuen Tong leads the digitalization of traditional Chinese medicine introducing Hong Kong’s first smart AI constitution analysis device, pioneers Hong Kong into a new era of healthcare in traditional Chinese medicine

HONG KONG, March 28, 2025 /PRNewswire/ — Wai Yuen Tong (0897.HK), a pioneer in traditional Chinese medicine in Hong Kong, announced that starting today, five core stores located in Percival Street Causeway Bay, Nathan Road Mong Kok, Cameron Road Tsim Sha Tsui, New Town Plaza Sha Tin, and Telford Plaza Kowloon Bay will initiate a trial introduction of the innovative Smart Traditional Chinese Medicine Health Profiling Device developed by Prevent Medical International Corporation. This marks Wai Yuen Tong’s entry into a new era of “AI Diagnosis” in traditional Chinese medicine services. Smart Traditional Chinese Medicine Health Profiling Device digitizes the four diagnostic methods of traditional Chinese medicine: observation, auscultation and olfaction, inquiry, and pulse feeling and palpation. Utilizing cloud-based intelligent algorithms for constitution recognition and integrating the twenty-four solar terms, it assesses customers’ traditional Chinese medicine health profiles. This initiative combines Wai Yuen Tong’s century-old commitment to pharmacological heritage with innovative technological advancements that enhance the accuracy of traditional diagnosis and treatment, transitioning traditional Chinese healthcare from “empirical medicine” to “data-driven” precision health management, benefiting the new generation living in Hong Kong’s fast-paced urban environment.

Diagnosis Integrates Big Data from Four Diagnostic Methods to Greatly Enhance Analytical Accuracy

The Smart Traditional Chinese Medicine Health Profiling Device introduced by Wai Yuen Tong is developed by the Prevent Medical International Corporation, a medical technology research and development platform company focused on creating an AI-driven, full-cycle system for traditional Chinese medicine. The company is dedicated to combining traditional Chinese medicine principles with modern technology to provide accurate and timely diagnosis, treatment, and prevention services in traditional Chinese medicine, empowering the entire smart traditional Chinese medicine landscape. Currently, the core technology of the Smart Traditional Chinese Medicine Health Profiling Device has received multiple certifications, including CCC certification (China Compulsory Certification), software copyright certificates, and national patent certificates for automatic recognition. This has attracted several domestic hospitals, traditional Chinese medicine universities, and wellness platform companies to incorporate the device to assist in diagnosis. To date, the device has reached over 2.4 million users. The Smart Traditional Chinese Medicine Health Profiling Device collects data from face-to-face consultations, tongue examinations, auscultation and olfaction, and inquiry, using cloud-based intelligent algorithms that integrate with the philosophy of the twenty-four solar terms to accurately analyze customers’ health profiles.

After introducing the device, Wai Yuen Tong has also upgraded its system by integrating its services. Following the assessment, customers not only receive a personalized comprehensive health profile report but can also implement targeted health improvement suggestions through Wai Yuen Tong’s wellness recommendations, allowing them to more effectively select suitable traditional Chinese medicine treatments and supplement products.

In Wai Yuen Tong stores, the Smart Traditional Chinese Medicine Health Profiling Device does not function as an independent technological exhibit; rather, it acts as a ‘smart partner’ in deep collaboration with registered traditional Chinese medicine practitioners. After the AI completes the data analysis, customers can have their health interpretation results verified by practitioners through pulse diagnosis, ultimately leading to personalized prescriptions. This process leverages the data integration advantages of AI while adhering to the essence of traditional Chinese medicine’s diagnostic principles of ‘Three Factors Adapting to Circumstances’ (considering the individual, the timing, and the location).

Ms. Vivian Tang, Executive Director of Wai Yuen Tong Medicine Holdings Limited said, ‘The challenge in traditional Chinese medicine diagnosis lies in the concept of “same disease, different treatment; different diseases, same treatment.” AI can quickly screen health profiles, while the practitioner’s experience captures the ‘human clues’ beyond the data. This complementary approach can reduce misdiagnosis rates, significantly enhance patient reassurance, and address the issues of digitalization and standardization in traditional Chinese medicine, improving the efficiency of practitioners’ diagnoses and treatments.’ With a century-old pharmacy shelf coexisting with smart screens in the consultation rooms, Wai Yuen Tong is innovatively demonstrating that technology is not the opposite of tradition but rather a nourishing element that allows ancient wisdom to take root in contemporary society.”

Wai Yuen Tong Constructs a ‘Traditional Chinese Medicine Big Health Ecosystem’ to Capture the Untapped Market of Preventive Medicine

According to data from the World Health Organization (WHO), better utilization of preventive measures could reduce the global disease burden by up to 70%. In response to the national directive in the ’14th Five-Year Plan for National Health’ which emphasizes the need to ‘implement major projects for the revitalization and development of traditional Chinese medicine and upgrade the health engineering project of “preventing diseases” with traditional Chinese medicine’, Wai Yuen Tong is keeping pace with the times. The company has introduced the Smart Traditional Chinese Medicine Health Profiling Device to achieve body constitution analysis and provide intelligent diagnosis results, thereby offering personalized solutions such as traditional Chinese medicine prescriptions and health supplements. At the same time, to deepen the application of preventive medicine, Wai Yuen Tong is currently collaborating with leading AI technology research institutions in the Greater Bay Area. By analyzing and organizing big data from consumers in the Greater Bay Area, the company aims to provide customized health solutions to residents, hoping to reduce the long-term risk of illness and enhance public awareness of the daily applications of traditional Chinese medicine health care. This supports the promotion of the national big health policy.

Embracing New Era Development to Pass Down Millennium-Old Wisdom of Traditional Chinese Medicine Through Technology

In light of rising global health awareness and the trend of digitalization, Wai Yuen Tong will continue to explore the digitalization and modernization of traditional Chinese medicine, striving for a deep integration of traditional culture and innovative technology. The brand plans to further popularize the application of intelligent AI in traditional Chinese medicine through technologies such as AI and big data, making ancient wisdom in diagnosis, health maintenance, and medicinal cuisine more relevant to modern life scenarios. This effort particularly aims to attract the younger generation to understand the scientific and practical value of traditional Chinese medicine.

Ms. Vivian Tang, Executive Director of Wai Yuen Tong Medicine Holdings Limited, emphasized, ‘The combination of big data calculations for AI in traditional Chinese medicine and the clinical experience of Wai Yuen Tong’s practitioners can further popularize the concept of “preventing diseases.” This enables the public to quickly and accurately perceive diseases and adopt preventive treatments, reducing the likelihood of illness or the progression of conditions into actionable lifestyle solutions. Wai Yuen Tong is dedicated to safeguarding public health, providing comprehensive traditional Chinese medicine services and support to every customer, and utilizing technology to ensure the sustainable inheritance of traditional Chinese medicine culture.'”

About Wai Yuen Tong Medicine Holdings Limited

Wai Yuen Tong Medicine Holdings Limited, a listed company on HKEX (Stock Code: 0897), is principally engaged in the production, processing and retailing of pharmaceutical and health products, including five major product categories of Chinese medicine (proprietary Chinese medicines, dietary supplement, homology of medicine and food, decoction and concentrated granule, and lifestyle products) under the brand name of “Wai Yuen Tong“, western pharmaceutical, health food and personal care products under the brand names of “Madame Pearl’s” and “Pearl’s”. Wai Yuen Tong has introduced one-stop Chinese medical and healthcare services. For more details, please visit https://www.wyth.net.

FY Ads Singapore: The Business Matchmaker Behind Trip.com, Haidilao Singapore, and Sichuan Airlines’ Iconic Chengdu Campaign

SINGAPORE, March 28, 2025 /PRNewswire/ — What happens when you bring together the excitement of travel, the irresistible appeal of hotpot, and the dynamic energy of Chengdu? You get a campaign that’s not only memorable but legendary. At FY Ads Singapore, we didn’t just organize an event – we acted as the business matchmaker between Trip.com, Haidilao Singapore, and Sichuan Airlines, creating an unforgettable cross-brand collaboration that captivated audiences both online and offline. Here’s how we brought this groundbreaking partnership to life.

Transforming Ideas into Impactful Experiences

Our mission was simple: establish Chengdu as a must-visit destination while highlighting the experiences offered by Trip.com, the culinary excellence of Haidilao Singapore, and the seamless travel service of Sichuan Airlines. The real challenge? Fostering a collaboration between these three brands and bringing their visions together. That’s where FY Ads came in as the business matchmaker, aligning their unique strengths to create a unified and powerful campaign.

The Strategy Behind the Success

Dream Big, Plan Smart

The foundation of our approach was based on creating synergy between the brands, with careful planning and attention to detail:

  • Thematic Brilliance: A campaign theme that intertwined Chengdu’s rich culture, exciting travel possibilities with Trip.com and Sichuan Airlines, and the vibrant dining culture of Haidilao Singapore.
  • Business Matchmaking: As the catalyst for this cross-brand collaboration, FY Ads played a crucial role in connecting the right brands at the right time, ensuring their offerings complemented each other perfectly.
  • Meticulous Planning: We took charge of every aspect, ensuring that each brand’s vision came to life seamlessly across all touchpoints, from online to offline engagement.

Creating Visuals That Captivate

The visuals were essential in driving the campaign’s success. Here’s how we brought it all together:

  • Immersive Event Designs: The physical event spaces were designed to reflect the unique aspects of each brand, with interactive setups that highlighted the cultural richness of Chengdu, the travel experience offered by Sichuan Airlines and Trip.com, and the mouthwatering dining experiences from Haidilao Singapore.
  • Co-branded Landing Page: A dynamic and user-friendly landing page that integrated the campaign theme while showcasing the collaboration between the three brands.
  • Social Media Masterpieces: High-quality videos, photos, and content that were perfectly tailored for platforms like Instagram and Xiaohongshu, amplifying the reach of the campaign online.

Flawless Execution On-Site and Online

When it comes to delivering an event that blends both physical and digital experiences, we take no shortcuts. Here’s how we ensured success:

  • On-Site Precision: We managed every detail of the offline event with precision – from the initial setup to real-time coordination, ensuring a smooth flow that highlighted the contributions of all three brands.
  • Online Amplification: We didn’t stop at the physical event – FY Ads ensured that the campaign reached a global audience through strategic online initiatives. By partnering with influencers, securing media placements, and driving content through social media, we maximized online engagement and visibility for Trip.com, Haidilao Singapore, and Sichuan Airlines.

Amplifying the Buzz Online and Beyond

To ensure the campaign had a far-reaching impact, we focused on both online and offline amplification:

  • Influencer Partnerships: We worked with influencers who authentically represented the campaign’s spirit, helping to drive genuine excitement for the collaboration between Trip.com, Haidilao Singapore, and Sichuan Airlines.
  • Media Placements: We secured high-value media placements in leading publications, ensuring the campaign was showcased in front of the right audiences both offline and online.
  • Social Media Campaigns: By curating engaging content and encouraging user-generated posts, we made sure the campaign stayed top of mind for audiences long after the event.

The Power Behind the Campaign’s Success

This wasn’t just an event – it was a powerful cross-brand collaboration made possible by FY Ads. By blending the strengths of Trip.com, Haidilao Singapore, and Sichuan Airlines, we were able to:

  • Showcase Chengdu as a must-visit destination, merging travel and dining in an innovative way.
  • Elevate the visibility of Trip.com, Haidilao Singapore, and Sichuan Airlines, ensuring each brand’s unique offering was front and center.
  • Drive sustained buzz and engagement, both online and offline, through strategic planning, influencer partnerships, and media placements.

Why FY Ads is Your Ideal Partner

At FY Ads, we don’t just plan events – we create extraordinary, cross-brand collaborations that resonate with audiences. Acting as the business matchmaker, we connect the right brands and bring their visions together in ways that are impactful and memorable. From crafting visually captivating experiences to amplifying campaigns online and offline, we ensure every project achieves its full potential.

Ready to create a campaign that will make waves? Let’s chat about how we can bring your vision to life and turn your next project into an unforgettable experience.

 

The Future of Oil: Market Trends, Risks, and Trading Potential with Octa Broker


KUALA LUMPUR, MALAYSIA – Media OutReach Neswire – 28 March 2025 – As of March 2025, Brent crude oil prices have experienced fluctuations: its price traded between $68.30 and slightly above $73 per barrel. This volatility reflects evolving macroeconomic factors and geopolitical dynamics. OPEC+ has announced plans to gradually increase oil production starting in April 2025, aiming to unwind 2.2 million barrels per day of previous cuts over an 18-month period. Despite global efforts to transition towards renewable energy sources, oil continues to play a pivotal role in the global economy. Octa Broker, a broker with globally recognised licenses, discusses the potential attractiveness of investments in oil in 2025 and the risks to consider.

Octa Broker
Octa Broker

Oil Price Forecasts for 2025: Expert Predictions

Oil can become a lucrative trade option in 2025. The U.S. Energy Information Administration (EIA) projects Brent crude oil prices to average $74 per barrel in 2025 and decline to $68 per barrel in 2026. Pickering Energy Partners’ Chief Investment Officer, Dan Pickering, expects oil prices to range between $65 and $75 per barrel in 2025 amid ongoing supply tightness and geopolitical risks.

According to Kar Yong Ang, financial market analyst at Octa Broker, oil remains a core asset for traders looking to hedge against inflation and geopolitical risk. He says that ‘Oil‘s price movements in 2025 will be shaped by supply-side decisions from OPEC+ and the geopolitical landscape. Traders should be prepared for volatility but also recognise the potential for trading opportunities in these market conditions.’ Global oil demand is projected to rise by 1.4 million barrels per day in 2025, driven by strong air travel and automotive demand. However, economic uncertainties, including tariff disputes and potential recession fears, have introduced near-term instability in the oil market.

Factors Affecting Oil Prices

Geopolitical tensions continue to be a leading force in the oil market. The current political tension and conflict in the principal areas of oil production can affect supply chains. Despite tensions simmering in the Middle East, strong global oil supply is keeping prices from shooting spectacularly.

OPEC+ remains the world’s dominant oil supplier, recently indicating a willingness to increase production—an outlook that can put pressure on prices. But non-OPEC producers, particularly U.S. shale firms, are significant as well. While U.S. production remains robust, its growth rate has slowed compared to recent years.

On the demand side, China remains the largest crude oil consumer, but its slowing economy is making the sector apprehensive about future demand. India, on its part, is continuing to exhibit healthy demand, underpinning market stability, while the U.S. is contributing to potential headwinds powered by tariff-related economic pressure. These supply-side-leading dynamics will play out with demand-side uncertainty and set the trajectory of the petroleum market over the next few months.

Oil Investment Potential in 2025 and Associated Risks

Oil has historically been a trusted inflation hedge, but in 2025 its direction is not at all obvious. The market is being pulled in two opposite directions by a mix of economic and geopolitical pressures, each with the power to move prices a lot.

On the downside, the spectre of a worldwide economic slowdown threatens the market. New tariffs and increasing trade tensions have the power to sap demand and therefore pull oil prices lower. Crude can plummet sharply if it turns for the worse, and a full-fledged recession sets in. Meanwhile, Middle East instability is building, and with Iran becoming increasingly involved, the risk of supply disruptions is increasing. If it escalates further, oil can come back hard.

OPEC has also complicated matters. The cartel has been increasing production, expecting demand to rise as well, but there is a very real chance that they overestimated. When demand doesn’t rise as much as hoped, the market is in an oversupply situation, and prices will be falling again.

And then there is the longer-term transformation. The worldwide push towards renewables is slowly reshaping energy markets, and while the transition won’t be instantaneous, it’s already tightening the screws on oil demand. Prices might not react in the near term, but the handwriting is on the wall.

Meanwhile, U.S. shale, once the biggest wild card in global oil supply, is no longer the unstoppable force that it was. Production is still robust, but growth has slowed, and most believe that the industry has already peaked. That is one reason that can potentially keep prices underpinned in the long term.

Weak demand forecasts by China were one of the key drivers of oil prices in 2024. In 2025 political tensions might give rise to supply shocks resulting in surprise price peaks, making oil a good option as a short-term trade. In the long term, the asset price may remain relatively stable or even decrease, as expected by the experts.

However, traders must balance risks before they invest, even in the short term. Oil prices are highly sensitive to geopolitical tensions, which may usher in unexpected price swings. Recessions in large economies, particularly China, may dampen demand, while the global shift towards alternative energy sources is a long-term threat to the supremacy of oil. In addition, overproduction by the oil-producing nations may result in lower prices and render it unprofitable for investors.

The Role of Oil in the Global Energy Transition

Oil companies are still expanding their portfolios into renewable energy investments, showing heightened interest in sustainability. Investment in clean energy by oil and gas companies rose to approximately USD 30 billion in 2023, which accounts for less than 4% of their overall capital expenditure. Notably, over 60% of this investment came from just four major companies: Equinor, TotalEnergies, Shell, and BP, highlighting that a small group of industry leaders are spearheading the transition. This push into wind, solar, and hydrogen investments, alongside continued oil production, provides new opportunities for traders to diversify their portfolios with both conventional energy assets and new renewables.

Practical Recommendations for Traders and Investors

To successfully trade the oil market in 2025, investors and traders can consider the following tips:

  1. Stay Informed on Market Fundamentals. For example, follow news regarding the key drivers of oil prices. To track oil prices effectively, focus on primary short-term influences. Geopolitical threats, especially in Ukraine and the Middle East, are sudden market changes. Central bank forecasts and interest rate manoeuvres influence demand macroeconomically. Political steps — tariffs, and sanctions — affect prices as well. Additionally, track EIA stockpile reports, also IEA and OPEC bulletins. These reports offer valuable insights into global energy supply and demand dynamics, allowing for a more comprehensive understanding of market trends and potential price fluctuations.
  2. Utilise Diverse Trading Instruments like ETFs or CFDs. The latter allows traders to speculate on the future movement of oil prices without having to own the underlying commodity, hence requiring smaller investments. ​
  3. Implement Robust Risk Management Strategies. Due to the high volatility of oil markets, effective risk management must be employed. This includes stop-loss orders, take-profits, portfolio diversification, and position sizing, which is advised not to exceed 1-2% of capital per trade.

2025 oil markets are a complex mix of risk and opportunity. Macro drivers such as world economic growth patterns and the pace towards renewables will drive medium- and long-term demand curves, but geopolitical tensions and supply-side pressures can underpin high price levels. Those who enter the market with a sophisticated research strategy — balancing fundamental and technical factors — will be well-equipped to navigate this changing landscape.

Oil companies’ ability to make renewable investments alongside traditional energy production highlights the sector’s ongoing development. Short-term volatility can be leveraged for tactical gains by traders, but long-term investors must ride the structural adjustments that are likely to define the industry for the next two decades. Good risk management, continuous market studies, and diversification in exposure will remain the keys to success as the energy sector evolves.

Disclaimer: Trading involves risks and may not be suitable for all investors. Use your expertise wisely and evaluate all associated risks before making an investment decision
Hashtag: #Octa

The issuer is solely responsible for the content of this announcement.

Octa

is an international CFD broker that has been providing online trading services worldwide since 2011. It offers commission-free access to financial markets and various services used by clients from 180 countries who have opened more than 52 million trading accounts. To help its clients reach their investment goals, Octa offers free educational webinars, articles, and analytical tools.

The company is involved in a comprehensive network of charitable and humanitarian initiatives, including the improvement of educational infrastructure and short-notice relief projects supporting local communities.

In Southeast Asia, Octa received the ‘Best Trading Platform Malaysia 2024’ and the ‘Most Reliable Broker Asia 2023’ awards from Brands and Business Magazine and International Global Forex Awards, respectively.

Shanton Reveals Topline Data from Phase 2b Study in Refractory Gout Patients

SAP-001 is Shanton’s lead investigational compound with First- and Best-in-Class potential in uncontrolled gout

SINGAPORE and PRINCETON, N.J., March 28, 2025 /PRNewswire/ — Shanton Pharma, a clinical-stage biotech company developing a novel treatment for gout, today announced topline data of a Phase 2b study in refractory gout patients with its investigational drug SAP-001 that uses a First-in-Class Mechanism of Action targeting a distinct kidney transporter.

“We are excited and very pleased with the outcome of our Phase 2b clinical study in this difficult-to-treat population of refractory gout patients” says Dr. Bing Li, Shanton’s CEO. “By the end of month 3 in our study, nearly 100% of patients that were confirmed exposed to daily SAP-001 30 and 60 mg dosages on top of conventional therapy reached the study’s therapeutical target (serum uric acid levels below 6mg/dL), compared to only about 10% of patients on conventional treatment who reached that goal. The majority of treatment effects persisted until the end of treatment at month 6 of the study. More than half of those patients confirmed exposed to a daily 60 mg dose reached serum uric acid levels below 3mg/dL. Importantly, the study demonstrated an excellent safety profile in this population.”

Shanton’s gout program already showed excellent, best-in-class efficacy compared to other Urate Lowering Therapies in prior Phase 1 and 2a studies in regular gout patients, an outcome that has now been repeated in the challenging target population of refractory patients that often have a more severe form of gout with limited treatment options. Dr. Wenfeng Miao, Shanton’s CMO adds: “This is the first successful clinical study with an oral gout drug to treat these refractory patients that normally need to be treated with an intravenous uricase. The efficacy of SAP-001 in this population is very impressive in all dosage groups at all assessed time points across the six months of treatment. We believe that the excellent efficacy and safety outcomes in this study show the exciting potential of our First-in-Class compound with its novel mechanism of action (MOA) that selectively targets a distinct kidney transporter for urate lowering treatment. The medical community has long been looking for this new mechanism in gout to address the shortcomings with conventional MOAs, especially where it comes to treating refractory and tophaceous patients. Our goal is to proceed into pivotal studies with our program later this year to eventually offer a paradigm-shifting gout treatment to our patients and make a big impact in their lives.”

About Gout

Gout is the most common form of inflammatory arthritis and the second most prevalent metabolic disease. It is caused by too much uric acid in the bloodstream, with over 12 million adult patients diagnosed in the US alone.1 Hyperuricemia, elevated serum uric acid levels, can over time result in gout when urate crystals are deposited in joints and other body tissues, causing inflammatory responses and painful gout attacks (flares). Recurrent gout flares are debilitating, and chronic gouty arthritis can over time lead to joint destruction and joint disfigurement.

About 29% of diagnosed gout patients in the US are treated with urate lowering therapies (ULTs), but only half of those patients sufficiently respond to or can tolerate current treatment options. It is estimated that up to 20% of US gout patients on standard-of-care allopurinol or febuxostat are physiologically refractory to these treatments. 2,3

About Shanton’s Phase 2b Gout Study

Shanton’s Phase 2b study is a six-month, multi-center, randomized, double-blind, placebo-controlled, dose-ranging clinical study in refractory gout patients with or without tophi, to evaluate the efficacy and safety of a 10, 30, or 60 mg tablet dose of SAP-001. The study enrolled 87 patients from 21 US sites.

The Primary objective is to assess the effectiveness of SAP-001 in lowering serum urate levels in gout patients that are refractory to standard-of-care Xanthine Oxidase Inhibitor (XOI) therapy. Secondary study objectives include safety and tolerability assessments and frequency of gout flares among others.

About Shanton Pharma

Shanton Pharma is a privately held, clinical-stage biotech founded in 2016 by experienced pharma entrepreneurs, with a research focus on unmet needs associated with hyperuricemia and gout. The company is headquartered in Singapore with research and development activities in the US, China, and Singapore.

SAP-001 is Shanton’s lead investigational compound for once-a-day oral urate-lowering therapy that targets refractory gout. SAP-001’s urate lowering properties are based on a unique mechanism-of-action and the product has shown unparalleled efficacy and safety in Phase 1 and Phase 2a clinical studies in gout patients with hyperuricemia, and now also has shown Best-in-Class efficacy and safety in gout patients with hyperuricemia refractory to Standard of Care Xanthine Oxidase Inhibitor therapy.

To learn more about Shanton Pharma, go to https://shantonpharma.com.

References

  1. Yokose C, McCormick N, Lu N, et al. Trends in Prevalence of Gout Among US Asian Adults, 2011-2018. JAMA Netw Open. 2023.
  2. Juraschek SP, Kovell LC, Miller ER 3rd, Gelber AC. Gout, urate-lowering therapy, and uric acid levels among adults in the United States. Arthritis Care Res (Hoboken). 2015.
  3. Clarivate Incidence and Prevalence Data Base

Media Contact

Pieter de Ridder
VP of Business Development
media@shantonpharma.com